CTNNB1 and hepatocellular carcinoma: have revealed that CTNNB1-mutated HCC is more accumulated in the ICI-resistant group than in the ICI-sensitive group21, which is consistent with the important finding that CTNNB1 mutation is enriched in non-T cell-inflamed tumors insusceptible to ICI therapy13.